Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT01652729. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Long-Term, Open-Label, 3-Arm, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To compare the effect on glycemic control (HbA1c) of exenatide suspension administered once weekly to that achieved by sitagliptin or placebo administered once daily for 28 weeks in subjects with type 2 diabetes mellitus.
Study identification
- NCT ID
- NCT01652729
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 365 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2013 (Type not available)
- Primary completion
- Apr 2014 (Actual)
- Completion
- Apr 2014 (Actual)
- Last update posted
- Aug 20, 2015
2013 – 2014
United States locations
- U.S. sites
- 60
- U.S. states
- 22
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35216 | — |
| Research Site | Huntsville | Alabama | 35801 | — |
| Research Site | Phoenix | Arizona | 85018 | — |
| Research Site | Phoenix | Arizona | 85020 | — |
| Research Site | Beverly Hills | California | 90036 | — |
| Research Site | Buena Park | California | 90620 | — |
| Research Site | Chino | California | 91710 | — |
| Research Site | Chula Vista | California | 91910 | — |
| Research Site | Encinitas | California | 92024 | — |
| Research Site | Greenbrae | California | 94904 | — |
| Research Site | Los Angeles | California | 90057 | — |
| Research Site | Los Angeles | California | 90059 | — |
| Research Site | North Hollywood | California | 91606 | — |
| Research Site | Walnut Creek | California | 94598 | — |
| Research Site | West Hills | California | 91307 | — |
| Research Site | Boca Raton | Florida | 33432 | — |
| Research Site | Hialeah | Florida | 33012 | — |
| Research Site | Miami | Florida | 33143 | — |
| Research Site | Miami | Florida | 33169 | — |
| Research Site | Miami | Florida | 33183 | — |
| Research Site | Port Orange | Florida | 32127 | — |
| Research Site | St. Petersburg | Florida | 33709 | — |
| Research Site | Chicago | Illinois | 60607 | — |
| Research Site | Evanston | Illinois | 60201 | — |
| Research Site | Indianapolis | Indiana | 46254 | — |
| Research Site | Oxon Hill | Maryland | 20745 | — |
| Research Site | Omaha | Nebraska | 68130 | — |
| Research Site | Henderson | Nevada | 89052 | — |
| Research Site | Las Vegas | Nevada | 89101 | — |
| Research Site | Las Vegas | Nevada | 89123 | — |
| Research Site | Albuquerque | New Mexico | 87102 | — |
| Research Site | Buffalo | New York | 14215 | — |
| Research Site | Hartsdale | New York | 10530 | — |
| Research Site | Charlotte | North Carolina | 28204 | — |
| Research Site | Clayton | North Carolina | 27520 | — |
| Research Site | Durham | North Carolina | 27710 | — |
| Research Site | Greensboro | North Carolina | 27410 | — |
| Research Site | Mooresville | North Carolina | 28117 | — |
| Research Site | Salisbury | North Carolina | 28144 | — |
| Research Site | Cincinnati | Ohio | 45246 | — |
| Research Site | Franklin | Ohio | 45005 | — |
| Research Site | Marion | Ohio | 43302 | — |
| Research Site | Yukon | Oklahoma | 73099 | — |
| Research Site | Eugene | Oregon | 97404 | — |
| Research Site | Portland | Oregon | 97210 | — |
| Research Site | Greer | South Carolina | 29651 | — |
| Research Site | Simpsonville | South Carolina | 29681 | — |
| Reseach Site | Rapid City | South Dakota | 57702 | — |
| Research Site | Chattanooga | Tennessee | 37421 | — |
| Research Site | Carrolton | Texas | 75007 | — |
| Research Site | Corpus Christi | Texas | 78404 | — |
| Research Site | Dallas | Texas | 75390 | — |
| Research Site | Houston | Texas | 77072 | — |
| Research Site | Houston | Texas | 77074 | — |
| Research Site | Katy | Texas | 77450 | — |
| Research Site | San Antonio | Texas | 78205 | — |
| Research Site | Salt Lake City | Utah | 84095 | — |
| Research Site | Salt Lake City | Utah | 84107 | — |
| Research Site | Burke | Virginia | 22015 | — |
| Research Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01652729, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 20, 2015 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01652729 live on ClinicalTrials.gov.